Literature DB >> 11193479

Inducible nitric oxide synthase expression in human urinary bladder cancer.

H Wolf1, C Haeckel, A Roessner.   

Abstract

Nitric oxide (NO) is generated by a family of enzymes, nitric oxide synthases (NOS), in a wide range of mammalian cells. NO produced by the inducible NOS isoform (iNOS) has been suggested to play an important role in tumor biology with both tumor promoter and anti-tumor activity. Here, the cellular localization of iNOS in tissue of 100 cases of urinary bladder cancer was assessed immunohistologically using a commercially available antiserum. Positive iNOS immunostaining was detected in all samples of tumor tissue, whereas nonmalignant tissue adjacent to malignant areas did not show any iNOS positivity. The tumor tissue revealed a highly inhomogeneous staining pattern. In addition to uniformly stained tumor specimens, we also found markedly iNOS-positive tumor islets in the midst of unstained tumor tissue and scattered individual tumor cells expressing marked staining. In some cases, the tumor tissue showed no or only weak staining intensity. In some instances, the superficial epithelial layer of papillary carcinomas was extremely immunoreactive, in other cases it was not. Thus we were unable to show a clear correlation to tumor grade or stage. Further studies with a diversity of tumor markers including molecular genetics techniques will be necessary to elucidate how and to what extent NO and bladder cancer of different grades and stages are functionally interrelated.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11193479     DOI: 10.1007/s004280000296

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  17 in total

1.  The Prolidase Activity, Oxidative Stress, and Nitric Oxide Levels of Bladder Tissues with or Without Tumor in Patients with Bladder Cancer.

Authors:  İlhan Gecit; Recep Eryılmaz; Servet Kavak; İsmail Meral; Halit Demir; Necip Pirinççi; Mustafa Güneş; Kerem Taken
Journal:  J Membr Biol       Date:  2017-08-16       Impact factor: 1.843

2.  Inducible nitric oxide synthase, nitrotyrosine and apoptosis in gastric adenocarcinomas and their correlation with a poor survival.

Authors:  Long-Gang Li; Hui-Mian Xu
Journal:  World J Gastroenterol       Date:  2005-05-07       Impact factor: 5.742

3.  Expression of nitric oxide synthase in human gastric carcinoma and its relation to p53, PCNA.

Authors:  Yong-Zhong Wang; You-Qing Cao; Jian-Nong Wu; Miao Chen; Xiao-Ying Cha
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

4.  Significance of inducible nitric oxide synthase expression in benign and malignant breast epithelium: an immunohistochemical study of 151 cases.

Authors:  Asiye Safak Bulut; Esra Erden; Serpil Dizbay Sak; Hatice Doruk; Nazmiye Kursun; Dilek Dincol
Journal:  Virchows Arch       Date:  2005-06-10       Impact factor: 4.064

5.  Evaluation of iNOS Expression in Esophageal Cancer Patients.

Authors:  Romina Barani; Gholamreza Motalleb; Hossein Maghsoudi
Journal:  Gastrointest Tumors       Date:  2016-03-17

6.  Nitric oxide synthase expression in human bladder cancer and its relation to angiogenesis.

Authors:  Zhen Lin; Shiping Chen; Chuanzhong Ye; Shaoxing Zhu
Journal:  Urol Res       Date:  2003-02-27

7.  Chemoprevention of Colon Cancer by iNOS-Selective Inhibitors.

Authors:  Naveena B Janakiram; Chinthalapally V Rao
Journal:  For Immunopathol Dis Therap       Date:  2012-01-01

8.  Induction of HSF1 expression is associated with sporadic colorectal cancer.

Authors:  Hui Cen; Shu Zheng; Yong-Ming Fang; Xiao-Ping Tang; Qi Dong
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

9.  Expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic adenocarcinoma: correlation with microvessel density.

Authors:  Hans-U Kasper; Hella Wolf; Uta Drebber; Helmut-K Wolf; Michael-A Kern
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

Review 10.  iNOS-selective inhibitors for cancer prevention: promise and progress.

Authors:  Naveena B Janakiram; Chinthalapally V Rao
Journal:  Future Med Chem       Date:  2012-11       Impact factor: 3.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.